Ligand Pharmaceuticals LGND Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's shares (basic)?
- Ligand Pharmaceuticals (LGND) reported shares (basic) of 19.9M in Q1 2026.
- How has Ligand Pharmaceuticals's shares (basic) changed year-over-year?
- Ligand Pharmaceuticals's shares (basic) increased by 3.6% year-over-year, from 19.2M to 19.9M.
- What is the long-term trend for Ligand Pharmaceuticals's shares (basic)?
- Over 4 years (2021 to 2025), Ligand Pharmaceuticals's shares (basic) has grown at a 3.9% compound annual growth rate (CAGR), from 66.5M to 77.4M.
- What does shares (basic) mean?
- The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.